Girish Kalva, MD | |
5058 South, Moray Ct, Holladay, UT 84117-3200 | |
(801) 913-7590 | |
(801) 272-6109 |
Full Name | Girish Kalva |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 28 Years |
Location | 5058 South, Moray Ct, Holladay, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821059544 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 5637572-1205 (Utah) | Secondary |
207R00000X | Internal Medicine | 5637572-1205 (Utah) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Highland Care Center | Holladay, UT | Nursing home |
Entity Name | University Of Utah Adult Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it has been granted U.S. patent No. 7,824,588 from the United States Patent and Trademark Office (USPTO). The patent, issued on November 2, 2010, provides intellectual property protection for the Company's film products and methods of their preparation.
The number of E. coli cases in Florida has now risen to 24 with the confirmation this week that two more people have E. coli bacteria poisoning.
SELLAS Life Sciences Group, a Swiss based, development-stage biopharmaceutical company with its main focus in developing innovative products for the treatment of various indications in Oncology and the Central Nervous System, today announced that it has signed an exclusive global collaboration and license agreement with TrojanTec Ltd, a UK-based Discovery Research and Development Company affiliated with Imperial College London, UK, for the development, marketing and commercialization of the innovative and proprietary TR-1 cancer therapeutic technology and drug.
Biothera has enhanced innate immune responses to its cancer immunotherapy drug candidate Imprime PGG in subjects regardless of biomarker status, demonstrating the opportunity to treat a larger patient population. The in vitro research will be presented today at the Cambridge Healthtech Institute's Antibody-Drug Conjugates/Engineering Targeted Therapeutics conference in Palm Springs, CA.
› Verified 7 days ago
Entity Name | Diagnopy Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750769220 PECOS PAC ID: 3779895107 Enrollment ID: O20150629000100 |
News Archive
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it has been granted U.S. patent No. 7,824,588 from the United States Patent and Trademark Office (USPTO). The patent, issued on November 2, 2010, provides intellectual property protection for the Company's film products and methods of their preparation.
The number of E. coli cases in Florida has now risen to 24 with the confirmation this week that two more people have E. coli bacteria poisoning.
SELLAS Life Sciences Group, a Swiss based, development-stage biopharmaceutical company with its main focus in developing innovative products for the treatment of various indications in Oncology and the Central Nervous System, today announced that it has signed an exclusive global collaboration and license agreement with TrojanTec Ltd, a UK-based Discovery Research and Development Company affiliated with Imperial College London, UK, for the development, marketing and commercialization of the innovative and proprietary TR-1 cancer therapeutic technology and drug.
Biothera has enhanced innate immune responses to its cancer immunotherapy drug candidate Imprime PGG in subjects regardless of biomarker status, demonstrating the opportunity to treat a larger patient population. The in vitro research will be presented today at the Cambridge Healthtech Institute's Antibody-Drug Conjugates/Engineering Targeted Therapeutics conference in Palm Springs, CA.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Girish Kalva, MD 5058 South, Moray Ct, Holladay, UT 84117-3200 Ph: (801) 913-7590 | Girish Kalva, MD 5058 South, Moray Ct, Holladay, UT 84117-3200 Ph: (801) 913-7590 |
News Archive
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it has been granted U.S. patent No. 7,824,588 from the United States Patent and Trademark Office (USPTO). The patent, issued on November 2, 2010, provides intellectual property protection for the Company's film products and methods of their preparation.
The number of E. coli cases in Florida has now risen to 24 with the confirmation this week that two more people have E. coli bacteria poisoning.
SELLAS Life Sciences Group, a Swiss based, development-stage biopharmaceutical company with its main focus in developing innovative products for the treatment of various indications in Oncology and the Central Nervous System, today announced that it has signed an exclusive global collaboration and license agreement with TrojanTec Ltd, a UK-based Discovery Research and Development Company affiliated with Imperial College London, UK, for the development, marketing and commercialization of the innovative and proprietary TR-1 cancer therapeutic technology and drug.
Biothera has enhanced innate immune responses to its cancer immunotherapy drug candidate Imprime PGG in subjects regardless of biomarker status, demonstrating the opportunity to treat a larger patient population. The in vitro research will be presented today at the Cambridge Healthtech Institute's Antibody-Drug Conjugates/Engineering Targeted Therapeutics conference in Palm Springs, CA.
› Verified 7 days ago
George Landon Beales, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 2146 Pheasant Lane, Holladay, UT 84121 Phone: 801-278-4965 | |
Stephen B Smith, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1624 E 4500 S, Holladay, UT 84117 Phone: 801-266-7200 Fax: 801-266-7004 | |
Dr. Sheetal Shah, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4252 S Highland Dr Ste 200, Holladay, UT 84124 Phone: 801-965-3600 |